An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.

In comparison with the placebo, ashwagandha supplementation was associated with a statistically significant reduction in the HAM-A ( P = .040) and a near-significant reduction in the DASS-21 ( P = .096).

also in 2,306 other papers

Ashwagandha intake was also associated with greater reductions in morning cortisol and DHEA-S; and a positive trend suggesting an increase in testosterone concentrations (the latter evidenced in men only).

also in 11,005 other papers

Compared with the placebo, ashwagandha intake was associated with a statistically significant, greater reduction in the HAM-A, although changes in the DASS-21 failed to reach statistical significance, despite a strong positive trend.

also in 6,035 other papers

However, between-group differences in DASS-21 changes did not reach statistical significance.

also in 111,027 other papers